GDUFA III: Controlled Correspondence U.S. Food and Drug Administration 8:01 1 year ago 2 866 Скачать Далее
GDUFA III Goal Date Illustrations U.S. Food and Drug Administration 14:24 1 year ago 2 535 Скачать Далее
A Deep Dive: GDUFA III Scientific Meetings U.S. Food and Drug Administration 2:57:33 1 year ago 4 894 Скачать Далее
DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Session 3 U.S. Food and Drug Administration 1:30:14 1 year ago 2 658 Скачать Далее
DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Keynote and Session 1 U.S. Food and Drug Administration 1:19:35 1 year ago 3 230 Скачать Далее
Facility Readiness: GMPs, Quality Assessments, and Compliance Trends (15of16) GDF 2020 U.S. Food and Drug Administration 52:19 4 years ago 5 130 Скачать Далее
DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Session 2 U.S. Food and Drug Administration 1:40:10 1 year ago 2 310 Скачать Далее
GDUFA III MCRM External Training Presentation final U.S. Food and Drug Administration 11:19 1 year ago 1 216 Скачать Далее
ANDAs: Pre-Submission Facility Correspondence (PFC) Related to Prioritized Generic Drug Submissions U.S. Food and Drug Administration 8:08 1 year ago 1 971 Скачать Далее
DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Session 4 and Closing Remarks U.S. Food and Drug Administration 1:29:48 1 year ago 1 897 Скачать Далее
Generic Drugs Forum (GDF) 2023: Celebrating 10 Years of the GDF – Day 1 – Session 3 U.S. Food and Drug Administration 2:01:10 1 year ago 657 Скачать Далее
GDUFA II Training - Requests for Reconsideration at the Division Level under GDUFA, Priya Shah U.S. Food and Drug Administration 10:52 6 years ago 981 Скачать Далее
Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval U.S. Food and Drug Administration 2:26:13 2 months ago 793 Скачать Далее
Generic Drug User Fees (GDUFA)- How do they Impact ANDA Holders and Type II DMF Holders? Webinar The Weinberg Group 58:05 10 years ago 1 869 Скачать Далее
Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access-Day 2, Pt 3 U.S. Food and Drug Administration 1:19:19 2 weeks ago 148 Скачать Далее
Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access - Day 1 U.S. Food and Drug Administration 8:06:51 Streamed 4 months ago 3 624 Скачать Далее
FDA Inspection Readiness: Expert Insights and Best Practices with Troy Fugate | Compliance Insight Compliance Insight 15:54 1 year ago 195 Скачать Далее
Drug Master Files from a GDUFA II User Fee Perspective U.S. Food and Drug Administration 15:13 3 years ago 984 Скачать Далее
GDUFA II Training - Goals Integration, Ted Sherwood U.S. Food and Drug Administration 7:48 6 years ago 630 Скачать Далее